Healthcare

HHS funds development of patient-controlled AI agents

HHS awarded $1.5 million for patient-controlled AI agents supporting clinical follow-up and laboratory interoperability.

The U.S. Department of Health and Human Services awarded $1.5 million to projects focused on agentic AI in clinical care and laboratory interoperability. The funding went to MedStar Health Research Institute and the Regenstrief Institute.

MedStar’s project is developing the Sovereign Execution Bridge, described as an open-source software framework for long-running clinical follow-up processes. The framework is intended to support patient-controlled data access and verifiable records of AI actions.

The projects address a healthcare challenge in which AI systems may need to coordinate tasks over extended periods rather than answer isolated questions. Patient control and traceability are central features of the reported work.

The development matters because it links agentic AI with governance mechanisms for clinical use. Open-source infrastructure, auditable actions and patient-controlled access could help make autonomous or semi-autonomous healthcare workflows more accountable and interoperable.

Original source: Becker's Hospital Review

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI